Skip to main content

Table 3 Clinical data of CAD patients undergoing CCTA and control group (\(\:\stackrel{-}{\varvec{x}}\pm\:\varvec{s}\))

From: Pericoronary adipose tissue radiomics features as imaging markers for coronary artery disease risk assessment: insights from gene expression analysis

 

CAD

Control group

P

Total

60

60

 

History of hypertension

30(50%)

48(80%)

P = 0.238

History of diabetes

42(70%)

3(5.0%)

P<0.0001*

Smoking history

25(41.67%)

13(21.6%)

P<0.0001*

Drinking history

17(28.33%)

19(31.7%)

P = 0.539

Cerebrovascular history

5(8.33%)

0(0%)

 

Family history

10(16.67%)

0(0%)

 

BMI (kg/m2)

25.83 ± 3.75

26.63 ± 4.27

P = 0.402

TC (mmol/L)

1.75 ± 1.52

1.67 ± 0.81

P = 0.548

TG (mmol/L)

3.71 ± 1.15

4.31 ± 1.09

P<0.0001*

HDL (mmol/L)

0.86 ± 0.25

1.03 ± 0.27

P<0.0001*

LDL (mmol/L)

2.07 ± 0.93

2.90 ± 0.89

P<0.0001*